<DOC>
	<DOCNO>NCT02700087</DOCNO>
	<brief_summary>All neonate , age 0 4 month , present LPCH pediatric ENT clinic airway difficulty stridor screen inclusion . As consistent acceptable standard medical care , child undergo flexible nasal endoscopic exam make diagnosis laryngomalacia , well weighed breastfeed history take . If laryngomalacia present , study staff administer Infant Gastroesophageal Reflux Questionnaire ( IGERQ ) airway symptoms questionnaire ( ASQ ) . Those baby IGERQ score less sixteen ( mild reflux ) ASQ score great six eligible randomization . The patient randomly place control group ( placebo ) intervention group ( ranitidine 2mg/kg every 12 hour famotidine 0.5 mg/kg daily ) . Patients stay medication minimum 6 month , symptom resolve . Patients see follow 1 , 2 , 3 , 4 , 5 , 6 , 8 10 month . At time I-GERQ , ASQ weight take . The primary outcome measure time ASQ score drop normal ranitidine famotidine versus placebo . A secondary outcome weight gain percentile . If patient 's I-GERQ score go 16 time study , patient cross treatment arm start medical treatment .</brief_summary>
	<brief_title>In Infants With Laryngomalacia , Does Acid-Blocking Medication Improve Respiratory Symptoms ?</brief_title>
	<detailed_description>Laryngomalacia , soft , floppy upper airway , common cause noisy breathing neonate . It cause combination factor include neuromuscular weakness , cartilaginous inadequacy , anatomic abnormality voice box . The majority affect baby ' symptom resolve one year without intervention , around 5 % case require surgical intervention treat failure thrive obstructive sleep apnea . Many baby laryngomalacia treat empirically H2 blocker ranitidine famotidine prevent reflux stomach acid cause inflammation already compromise upper airway . However , date study perform show definitive benefit medication . The investigator hope determine whether H2 blocker ranitidine famotidine improve airway symptom baby laryngomalacia . This effect practice guideline one common problem encounter pediatric otolaryngology . All neonate , age 0 4 month , present LPCH pediatric ENT clinic airway difficulty stridor screen inclusion . As consistent acceptable standard medical care , child undergo flexible nasal endoscopic exam make diagnosis laryngomalacia , well weighed breastfeed history take . If laryngomalacia present , study staff administer Infant Gastroesophageal Reflux Questionnaire ( IGERQ ) airway symptoms questionnaire ( ASQ ) . Those baby IGERQ score less sixteen ( mild reflux ) ASQ score great six eligible randomization . The patient randomly place control group ( placebo ) intervention group ( ranitidine 2mg/kg every 12 hour famotidine 0.5 mg/kg daily ) . Patients stay medication minimum 6 month , symptom resolve . Patients see follow 1 , 2 , 3 , 4 , 5 , 6 , 8 10 month . At time I-GERQ , ASQ weight take . The primary outcome measure time ASQ score drop normal ranitidine famotidine versus placebo . A secondary outcome weight gain percentile . If patient 's I-GERQ score go 16 time study , patient cross treatment arm start medical treatment .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Signs Symptoms , Respiratory</mesh_term>
	<mesh_term>Laryngomalacia</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<criteria>age 0 4 month old stridor flexible laryngoscopy demonstrate laryngomalacia airway symptom score 4 physiologic GER ( IGERQ &lt; 16 ) require surgery LGM airway dz see flexible laryngoscopy history already PPI therapy minimal/mild airway symptom ( airway score &lt; 4 ) pathologic GERD ( IGERQ great 16 ) These pt randomize standard score Pediatric GI literature strongly indicate antireflux med premature birth ( &lt; 36 week )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Laryngomalacia</keyword>
</DOC>